
Nayan Pharmaceuticals Limited
Manufactures medicines and pharmaceutical goods since 1996 in Punjab.
Manufactures medicines and pharmaceutical goods since 1996 in Punjab.
Nayan Pharmaceuticals Limited (NPL) is a Public Limited Indian Non-Government Company incorporated in India on 26 November 1996 and has a history of 28 years and six months. Its registered office is in Patiala, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.91 M.
The company currently has active open charges totaling ₹2.30 M. The company has closed loans amounting to ₹0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Shiv Srivastava, Akshay Srivastava, and Manohar Verma serve as directors at the Company.
Patiala, Punjab, India
+91-XXXXXXXXXX
U24231PB1996PLC019085
019085
Public Limited Indian Non-Government Company
26 Nov 1996
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chandigarh
Nayan Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Arthritic Drugs, Cough Syrup, Digestive System Drugs & Medicines, Antacid Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shiv Srivastava ![]() | Director | 26-Nov-1996 | Current |
Akshay Srivastava ![]() | Director | 16-Jul-2016 | Current |
Manohar Verma ![]() | Director | 14-Dec-2022 | Current |
Nayan Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.53% increase. The company also saw a substantial improvement in profitability, with a 531.29% increase in profit. The company's net worth moved up by a moderate rise of 6.61%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Nayan Pharmaceuticals had a promoter holding of 96.15% and a public holding of 3.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹2.30 M
₹0.90 M
Date | Lender | Amount | Status |
---|---|---|---|
30 Oct 2023 | Canara Bank | ₹1.60 M | Open |
07 Jan 1998 | Canara Bank | ₹0.70 M | Open |
13 Aug 2009 | Canara Bank | ₹0.50 M | Satisfied |
07 Jan 1998 | Canara Bank | ₹0.40 M | Satisfied |
Unlock and access historical data on people associated with Nayan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nayan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nayan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nayan Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Nayan Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
A charge with Canara Bank amounted to Rs. 1.60 M with Charge ID 100835999 was registered on 30 Oct 2023.
Manohar Lal Verma was appointed as a Director was appointed as a Director on 14 Dec 2022 & has been associated with this company since 2 years 5 months .
A charge registered on 07 Jan 1998 via Charge ID 90173517 with Canara Bank was fully satisfied on 27 Oct 2022.
A charge registered on 13 Aug 2009 via Charge ID 10174432 with Canara Bank was fully satisfied on 26 Oct 2022.
Nayan Pharmaceuticals Limited was incorporated on 26 Nov 1996.
The authorized share capital of Nayan Pharmaceuticals Limited is ₹ 2.00 M and paid-up capital is ₹ 0.91 M.
Currently 3 directors are associated with Nayan Pharmaceuticals Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Nayan Pharmaceuticals Limited is Deelwal Morh Distt Patiala India, Punjab, 147001.
The corporate identification number (CIN) of Nayan Pharmaceuticals Limited is U24231PB1996PLC019085 and the company number is 019085 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Nayan Pharmaceuticals Limited has risen by 49.53%.
The financial reports for the fiscal year 2022 indicates that The net worth of Nayan Pharmaceuticals Limited has experienced an upsurge of 6.61%.
As per the financial statements for fiscal Year 2022, The total open charges for Nayan Pharmaceuticals Limited amount to ₹ 2.30 M.
The most recent Balance Sheet for Nayan Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
TB
PK